Erdafitinib is a therapy specifically made for treating metastatic urothelial cancer. It’s for cancer cells that have these specific FGFR2 or FGFR3 changes. It’s part of the FGFR inhibitor group, which blocks the Fibroblast Growth Factor Receptors, mainly focusing on the changed versions.
These tabs come in 3mg, 4mg, and 5mg. You start with 8mg a day, but can go up to 9mg if it helps work better. Each bottle has 56 of these tablets.
That’ll give you a month’s worth with the right dose, based on what’s recommended.
